FdaApplication
NDA 019564
Identifiers
- fda_app_no: NDA019564
Properties
| Property | Value |
|---|---|
| applicant_name | ABBOTT LABORATORIES PHARMACEUTICAL PRODUCTS DIV |
| application_type | NDA |
| approval_date | 1986-12-16 |
Products (4)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| AMINOSYN II 3.5% M IN DEXTROSE 5% IN PLASTIC CONTAINER | AMINO ACIDS; DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE | 3.5%;5GM/100ML;30MG/100ML;97MG/100ML;120MG/100ML;49.3MG/100ML | INJECTABLE;INJECTION |
| AMINOSYN II 3.5% W/ ELECTROLYTES IN DEXTROSE 25% IN PLASTIC CONTAINER | AMINO ACIDS; DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM CHLORIDE | 3.5%;25GM/100ML;51MG/100ML;22.4MG/100ML;261MG/100ML;205MG/100ML | INJECTABLE;INJECTION |
| AMINOSYN II 4.25% M IN DEXTROSE 10% IN PLASTIC CONTAINER | AMINO ACIDS; DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE | 4.25%;10GM/100ML;30MG/100ML;97MG/100ML;120MG/100ML;49.3MG/100ML | INJECTABLE;INJECTION |
| AMINOSYN II 4.25% W/ ELECTROLYTES IN DEXTROSE 25% IN PLASTIC CONTAINER | AMINO ACIDS; DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM CHLORIDE | 4.25%;25GM/100ML;51MG/100ML;22.4MG/100ML;261MG/100ML;205MG/100ML | INJECTABLE;INJECTION |
4 products